Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia

Summary

The purpose of the study is to assess the efficacy, safety and tolerability of NGX 4010 applied for 60 minutes for the treatment of PHN.

Timeline

Start

—

Primary completion

—

Completion

—

Outcome

Missed primary endpoint

paper NGX-4010 group (36.5%) compared with control (29.9%) although the difference was not significant (p = 0.296). PMID 20937130 ↗

Publications

• Webster LR, Tark M, Rauck R, Tobias JK, Vanhove GF. Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia. BMC Neurol. 2010 Oct 11;10:92. doi: 10.1186/1471-2377-10-92.

Drugs

Indications